As 20 million pregnancies worldwide are classified as high-risk annually, AI technology supports more consistent prenatal ...

Doctors say a high-risk pregnancy does not mean an unsafe delivery. With advances in genetic testing, prenatal screening, and personalised care, risks can now be detected earlier and managed ...

Clinical measures and biomarkers during pregnancy, including hs-cTnI and sFlt-1, can help identify women at higher risk of developing cardiovascular disease later in life.

Women who experience pregnancy complications, like preeclampsia, pre-term birth, stillbirth or having a baby that is small for gestational age, may face an increased risk for cardiovascular disease ...

Congenital heart defects (CHD) represent the most common congenital malformations globally and constitute a leading cause of neonatal mortality, with early maternal risk factors playing significant ...

Prenatal, childbirth-related, and postpartum risk factors drive childbirth-related posttraumatic stress symptoms, with ...

Clinical measures and blood biomarkers collected during pregnancy could offer early insight into a woman’s long-term cardiovascular health.

Discontinuing statins before pregnancy does not increase maternal cardiovascular risk, even in patients with pre-existing atherosclerotic disease.

The stresses of an uncertain future and social isolation specific to COVID-19 have intensified the experiences of the postpartum period. The stresses of an uncertain future and social isolation ...